Skip to content
cccskills
FreePublished on GitHub

es-cushing-urgent-treatment-life-threatening-complications

This skill recommends urgent treatment (within 24–72 hours) of hypercortisolism when life‑threatening complications of Cushing's syndrome such as infection, pulmonary thromboembolism, cardiovascular events, or acute psychosis are present. Trigger phrases include sepsis, PE, chest pain with hemodynamic instability, new‑onset psychosis, or delirium in a patient with known or suspected Cushing's.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md3.8 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Urgent Treatment Within 24-72 Hours of Hypercortisolism for Life-Threatening Complications of Cushing's Syndrome

STEP 1 — Gather Information

Collect history of Cushing's syndrome (diagnosis or high suspicion), vital signs, and symptoms suggesting life‑threatening complications: fever, leukocytosis, hypoxia, new cough or pleuritic pain (PE), chest pain, arrhythmia, hypotension, altered mental status, hallucinations, delusions, or agitation. Order CBC, CMP, CRP, blood cultures, D‑dimer, CT pulmonary angiogram, ECG, troponin, urine free cortisol, late‑night salivary cortisol, and dexamethasone suppression test if diagnosis not yet confirmed. Assess ability to take oral medications and renal/hepatic function.

STEP 2 — Rule In / Rule Out

Is there a life‑threatening complication likely driven by hypercortisolism? If yes, proceed to Step 3; if no, manage the complication per standard pathways and reconsider urgent cortisol‑lowering therapy only if hypercortisolism worsens.

STEP 3 — Classify or Stratify

Classify the complication: (A) Infection/sepsis, (B) Pulmonary thromboembolism, (C) Cardiovascular instability (ischemia, arrhythmia, heart failure), (D) Acute psychosis with safety risk. This classification guides adjunctive therapy while planning cortisol reduction.

STEP 4 — Decide

Initiate urgent cortisol‑lowering therapy within 24‑72 h: oral ketoconazole 400‑1600 mg/day divided q6‑8h (or metyrapone 500 mg‑6 g/day q6‑8h) if PO tolerated; if NPO or critically ill, start IV etomidate infusion titrated to maintain serum cortisol 10‑20 µg/dL; alternatively, use mifepristone 300‑1200 mg/day when diabetes/glucose intolerance is present. Simultaneously treat the underlying condition: antibiotics for infection, therapeutic anticoagulation for PE, anti‑ischemic measures or ICU cardiovascular support, low‑dose antipsychotic (e.g., haloperidol) for psychosis, and address associated disorders (correct hypokalemia, give stress‑dose hydrocortisone only after cortisol falls if adrenal insufficiency develops).

Clinical Guardrails / Mimics / Pitfalls

Do not delay cortisol‑lowering awaiting full biochemical confirmation if the patient is deteriorating; avoid glucocorticoids that could exacerbate hypercortisolism; avoid estrogen‑containing products; monitor QT prolongation when using antipsychotics or certain antifungal agents; watch for adrenal insufficiency after steroidogenesis inhibition and provide stress‑dose hydrocortisone only after cortisol levels fall; avoid medications that increase cortisol (e.g., exogenous ACTH); adjust doses for renal/hepatic impairment.

Concrete Clinical Example

A 48‑year‑old man with known ectopic ACTH syndrome presents with fever 39 °C, hypotension 80/50 mm Hg, confusion, and WBC 22 K; urine free cortisol 1200 µg/dL; CT pulmonary angiogram shows bilateral segmental PEs. Start IV etomidate infusion at 0.05 mg/kg/h to target cortisol 10‑20 µg/dL, begin therapeutic heparin infusion, give piperacillin‑tazobactam, and haloperidol 0.5 mg IV q8h for agitation. Admit to ICU, reassess cortisol q6h and transition to oral ketoconazole once stable.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., Endocrine Society, 2015, DOI:10.1210/jc.2015-1818

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill